lncRNA SNHG5 Modulates Endometrial Cancer Progression via the miR-25-3p/BTG2 Axis

<div>Expression of SNHG5 analyzed in the tumor sequencing public database. The RNA level of SNHG5 in different cancer types was analyzed using the public databases TIMER (<a href="https://cistrome.shinyapps.io/timer/">https://cistrome.shinyapps.io/timer/</a>) and GEPIA (<a href="http://gepia.cancer-pku.cn/">http://gepia.cancer-pku.cn/</a>). (a) SNHG5 was downregulated in EC. (b) SNHG5 showed the lowest level in stage IV compared to stages I–III. (c, d) EC patients with lower levels of SNHG5 showed a shorter survival time and disease-free survival times.</div>

Journal of Oncology

fig1

Figure 1

Figure 1: lncRNA SNHG5 Modulates Endometrial Cancer Progression via the miR-25-3p/BTG2 Axis 